(Q45871777)

17 December 2017

title

What is the status of gene therapy for primary immunodeficiency? (English)

1 reference

17 December 2017

0 references

R Michael Blaese

1

1 reference

17 December 2017

publication date

1 January 2007

1 reference

17 December 2017

published in

Immunologic Research

1 reference

17 December 2017

volume

38

1 reference

17 December 2017

issue

1-3

1 reference

17 December 2017

page(s)

274-284

1 reference

17 December 2017

Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1.

cites work

1 reference

12 December 2020

Highly efficient endogenous human gene correction using designed zinc-finger nucleases

1 reference

12 December 2020

Immune response to fetal calf serum by two adenosine deaminase-deficient patients after T cell gene therapy

1 reference

12 December 2020

Persistence and expression of the adenosine deaminase gene for 12 years and immune reaction to gene transfer components: long-term results of the first clinical gene therapy trial.

1 reference

12 December 2020

Gene transfer into humans--immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction

1 reference

12 December 2020

Progress toward effective gene therapy for chronic granulomatous disease.

1 reference

12 December 2020

Treatment of adenosine deaminase deficiency with polyethylene glycol-modified adenosine deaminase

1 reference

12 December 2020

Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning

1 reference

12 December 2020

T lymphocyte-directed gene therapy for ADA- SCID: initial trial results after 4 years.

1 reference

12 December 2020

Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease

1 reference

12 December 2020

Retroviral Vector-mediated Gene Transfer and Expression in Nonhuman Primates Following Autologous Bone Marrow Transplantation

1 reference

12 December 2020

Gene therapy of X-linked severe combined immunodeficiency by use of a pseudotyped gammaretroviral vector

1 reference

12 December 2020

T lymphocytes with a normal ADA gene accumulate after transplantation of transduced autologous umbilical cord blood CD34+ cells in ADA-deficient SCID neonates.

1 reference

12 December 2020

Engraftment of gene-modified umbilical cord blood cells in neonates with adenosine deaminase deficiency

1 reference

12 December 2020

Gene therapy in peripheral blood lymphocytes and bone marrow for ADA- immunodeficient patients

1 reference

12 December 2020

LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1

1 reference

12 December 2020

Bone marrow gene transfer in three patients with adenosine deaminase deficiency.

1 reference

12 December 2020

Stable and functional lymphoid reconstitution of common cytokine receptor gamma chain deficient mice by retroviral-mediated gene transfer

1 reference

12 December 2020

10.1007/S12026-007-0009-Z

Identifiers

DOI

1 reference

17 December 2017

Dimensions Publication ID

1015389965

0 references

1 reference

17 December 2017